Loading organizations...
Loading organizations...
Biopharmaceutical company developing immune cell treatments for tumors.
Hengruiyuan has raised $42.6M across 2 funding rounds.
Hengruiyuan has raised $42.6M in total across 2 funding rounds.
Hengruiyuan has raised $42.6M in total across 2 funding rounds.
Hengruiyuan's investors include Zhongke Kecai, Zijin Port Capital.
Hengruiyuan has raised $42.6M across 2 funding rounds. Most recently, it raised $14.0M Series C in January 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 9, 2024 | $14.0M Series C | Zhongke Kecai, Zijin Port Capital | |
| May 17, 2023 | $28.6M Series C |